Literature DB >> 3499573

Both immature and mature T cells mobilize Ca2+ in response to antigen receptor crosslinking.

T H Finkel1, M McDuffie, J W Kappler, P Marrack, J C Cambier.   

Abstract

T cells develop from prothymocytes which express no detectable antigen receptors to immature thymocytes with few receptors, eventually becoming mature thymocytes and peripheral T cells with 20,000-40,000 receptors per cell. Recent studies suggest that immature thymocytes are immunologically unresponsive. We have suggested that an early step in signal transduction following engagement of the T cell receptor might differ in immature and mature T cells. Here we examine anti-receptor antibody mediated induction of calcium mobilization in immature and mature T cells. Results indicate that antigen receptors on both immature and mature receptor-positive T cells transduce signals via calcium mobilization. Significant differences were observed, however, between these populations in the magnitude of influx of extracellular Ca2+ following binding of antireceptor antibody. Specifically immature cells show a much reduced Ca2+ influx response compared to mature cells which could result from a low Ca2+ channel frequency in the plasma membranes of immature T cells, or from less efficient activation of existing channels.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3499573     DOI: 10.1038/330179a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  20 in total

1.  Thymocyte development is normal in CTLA-4-deficient mice.

Authors:  C A Chambers; D Cado; T Truong; J P Allison
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

Review 2.  Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires.

Authors:  C C Goodnow
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

3.  Subcellular distribution of Lck during CD4 T-cell maturation in the thymic medulla regulates the T-cell activation threshold.

Authors:  Tom Li Stephen; Bridget S Wilson; Terri M Laufer
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-23       Impact factor: 11.205

4.  Src-like adaptor protein down-regulates T cell receptor (TCR)-CD3 expression by targeting TCRzeta for degradation.

Authors:  Margaret D Myers; Leonard L Dragone; Arthur Weiss
Journal:  J Cell Biol       Date:  2005-07-18       Impact factor: 10.539

5.  The Bacterial Peptidoglycan-Sensing Molecules NOD1 and NOD2 Promote CD8+ Thymocyte Selection.

Authors:  Marianne M Martinic; Irina Caminschi; Meredith O'Keeffe; Therese C Thinnes; Raelene Grumont; Steve Gerondakis; Dianne B McKay; David Nemazee; Amanda L Gavin
Journal:  J Immunol       Date:  2017-02-15       Impact factor: 5.422

6.  Developmental regulation of TCR-CD3-dependent [Ca2+]i responses of individual normal and pp59fyn-deficient T lymphocytes.

Authors:  K E Hedin; M W Appleby; D E Clapham
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

7.  Constitutive tyrosine phosphorylation of the T-cell receptor (TCR) zeta subunit: regulation of TCR-associated protein tyrosine kinase activity by TCR zeta.

Authors:  N S van Oers; W Tao; J D Watts; P Johnson; R Aebersold; H S Teh
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

8.  Subcellular localization of T-cell receptor complexes containing tyrosine-phosphorylated zeta proteins in immature CD4+CD8+ thymocytes.

Authors:  K P Kearse; D L Wiest; A Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

9.  Altered antigen receptor signaling in anergic T cells from self-tolerant T-cell receptor beta-chain transgenic mice.

Authors:  M A Blackman; T H Finkel; J Kappler; J Cambier; P Marrack
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

10.  Phenotypic and functional analysis of positive selection in the gamma/delta T cell lineage.

Authors:  F B Wells; Y Tatsumi; J A Bluestone; S M Hedrick; J P Allison; L A Matis
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.